Abstract:BACKGROUND:Chronic itch is a highly debilitating symptom that underlies many medical disorders with no universally effective treatments. Although unique neuronal signaling cascades in the sensory ganglia and spinal cord have been shown to critically promote the pathogenesis of chronic itch, the role of skin-associated cells remains poorly understood. OBJECTIVE:We sought to examine the cutaneous mechanisms underlying transient receptor potential vanilloid 4 (TRPV4)-mediated allergic and nonallergic chronic itch. METHODS:Expression of TRPV4 in chronic itch and healthy control skin preparations was examined by using real-time RT-PCR. Trpv4eGFP mice were used to study the expression and function of TRPV4 in the skin by means of immunofluorescence staining, flow cytometry, calcium imaging, and patch-clamp recordings. Genetic and pharmacologic approaches were used to examine the role and underlying mechanisms of TRPV4 in mouse models of dry skin-associated chronic itch and spontaneous scratching associated with squaric acid dibutylester-induced allergic contact dermatitis. RESULTS:TRPV4 is selectively expressed by dermal macrophages and epidermal keratinocytes in mice. Lineage-specific deletion of TRPV4 in macrophages and keratinocytes reduces allergic and nonallergic chronic itch in mice, respectively. Importantly, TRPV4 expression is significantly increased in skin biopsy specimens from patients with chronic idiopathic pruritus in comparison with skin from healthy control subjects. Moreover, TRPV4-dependent chronic itch requires 5-hydroxytryptamine (5-HT) signaling secondary to activation of distinct 5-HT receptors in mice with allergic and those with nonallergic chronic itch conditions. CONCLUSION:Our study reveals previously unrecognized mechanisms by which TRPV4-expressing epithelial and immune cells in the skin critically and dynamically mediate chronic itch and unravels novel targets for therapeutics in the setting of chronic itch.

The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases

The Ca 2 1-Permeable Cation Transient Receptor Potential TRPV 3 Channel : An Emerging Pivotal Target for Itch and Skin Diseases

Novel Insights into the Role of Keratinocytes-Expressed TRPV3 in the Skin

Heteromeric Heat-sensitive Transient Receptor Potential Channels Exhibit Distinct Temperature and Chemical Response

Unlocking the therapeutic potential of TRPV3: Insights into thermosensation, channel modulation, and skin homeostasis involving TRPV3

Molecular Basis for Heat Desensitization of TRPV1 Ion Channels.

Exploring Functional Roles of TRPV1 Intracellular Domains with Unstructured Peptide-Insertion Screening.

Role of Thermotrp Channels in Cutaneous Neurogenic Inflammation and Itch

Enhanced Thermal Sensitivity of TRPV3 in Keratinocytes Underlies Heat-Induced Pruritogen Release and Pruritus in Atopic Dermatitis

Anti-pruritic and Anti-Inflammatory Effects of Natural Verbascoside Through Selective Inhibition of Temperature-Sensitive Ca2+-permeable TRPV3 Channel

Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment

Irritant-evoked activation and calcium modulation of the TRPA1 receptor

A pivotal role for the activation of TRPV3 channel in itch sensations induced by the natural skin sensitizer carvacrol

Inhibition of the Warm Temperature-Activated Ca 2+ -Permeable Transient Receptor Potential Vanilloid TRPV3 Channel Attenuates Atopic Dermatitis.

The Role of TRPA1 in Skin Physiology and Pathology

Inhibition of Warm Temperature‐sensitive and Ca2+‐permeable TRPV3 Channel by a Novel Compound QDULM‐12 for Anti‐pruritus and Dermatitis

TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases

Inhibition of Temperature-Sensitive TRPV3 Channel by Two Natural Isochlorogenic Acid Isomers for Alleviation of Dermatitis and Chronic Pruritus

TRPV4-β-catenin axis is a novel therapeutic target for dry skin-induced chronic itch

PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes

Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch.